香港股市 將收市,收市時間:1 小時 50 分鐘

Merck & Co., Inc. (MRK)

NYSE - NYSE 延遲價格。貨幣為 USD。
加入追蹤清單
105.53-1.40 (-1.31%)
收市價: 04:03PM EDT
107.00 +1.47 (+1.39%)
收市後: 07:58PM EDT
全螢幕
交易股價資料並非來自所有市場
前收市價106.93
開市106.61
買盤0.00 x 900
賣出價0.00 x 800
今日波幅105.43 - 107.03
52 週波幅81.64 - 115.49
成交量6,584,867
平均成交量8,895,203
市值267.897B
Beta 值 (5 年,每月)0.35
市盈率 (最近 12 個月)18.48
每股盈利 (最近 12 個月)5.71
業績公佈日2023年4月27日
遠期股息及收益率2.92 (2.73%)
除息日2023年3月14日
1 年預測目標價119.54
  • Insider Monkey

    12 Best Diversified Dividend Stocks to Buy Now

    In this article, we discuss 12 diversified dividend stocks to buy now. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Best Diversified Dividend Stocks to Buy Now. Diversified companies can provide investors with diversification across different industries and sectors, which can help reduce […]

  • Benzinga

    Merck Releases Keytruda Data In Frontline Endometrial Cancer Patients

    Merck & Co Inc (NYSE: MRK) announced results from the Phase 3 NRG‑GY018 trial of Keytruda (pembrolizumab) combined with standard-of-care chemotherapy (carboplatin and paclitaxel), then continued as a single agent every six weeks for up to 14 cycles for the first-line treatment of stage III-IV or recurrent endometrial carcinoma whose cancer was either mismatch repair proficient (pMMR) or mismatch repair deficient (dMMR). Keytruda, in combination with chemotherapy, reduced the risk of disease prog

  • Insider Monkey

    What Makes Merck & Co. (MRK) A Strong Investment?

    Aristotle Capital Management, LLC, an investment management company, released its “Value Equity Strategy” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, the fund returned 10.57% gross of fees, underperforming the Russell 1000 Value Index, which returned 12.42%. The underperformance of the fund relative to the benchmark in […]